Addex Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.11.24	Addex Therapeutics Q3 Net Loss Narrows, Income Drops (RTTNews)
30.09.24	Addex Therapeutics Turns To Net Profit In Q2; Income Down (RTTNews)
22.07.24	Addex's Partner J&J Innovative Medicine Discontinues ADX71149 Development In Epilepsy (RTTNews)
15.07.24	Addex Therapeutics Presents Positive Results From GABAB PAM Cough Program (RTTNews)
06.06.24	Addex Therapeutics Q1 Net Loss Widens, Income Drops (RTTNews)
03.04.24	Addex Announces Launch Of Neurosterix In Partnership With Perceptive - Quick Facts (RTTNews)
29.11.23	Addex Therapeutics Posts Narrower Loss In Q3 - Quick Facts (RTTNews)
20.10.23	Press Release: Addex Completes ADS Ratio Change (Dow Jones)
06.10.23	Addex To Implement ADS Ratio Change (RTTNews)
06.10.23	Press Release: Addex Announces Plan to Implement ADS Ratio Change (Dow Jones)
20.09.23	Press Release: Addex mGlu2 NAM Cognition Program Receives EUR4 Million Grant (Dow Jones)
05.09.23	Press Release: Addex ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Q2 2024 (Dow Jones)
10.08.23	Press Release: Addex Reports 2023 Half Year and -2- (Dow Jones)
10.08.23	Press Release: Addex Reports 2023 Half Year and Second Quarter Financial Results and Provides Corporate Update (Dow Jones)
09.08.23	Ausblick: Addex Therapeutics zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
03.08.23	Press Release: Addex GABAB Positive Allosteric Modulator Program to Receive Additional CHF2.7 Million from Indivior in Extended Substance Use Disorder Resear... (Dow Jones)
23.07.23	Erste Schätzungen: Addex Therapeutics stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
18.05.23	Addex Receives Compliance Notification From Nasdaq (RTTNews)
10.05.23	Press Release: Addex Announces ADX71149 Phase 2 Epilepsy Clinical Study's Independent Interim Review Committee Recommends Continuing Study (Dow Jones)
05.04.23	Press Release: Addex Completes $5.0 Million Equity Financing (Dow Jones)
03.04.23	Press Release: Addex Raises $5.0 Million in Equity Financing (Dow Jones)
30.03.23	Addex Therapeutics FY22 Loss Widens, Income Down (RTTNews)
30.03.23	Press Release: Addex Reports Full Year 2022 -2- (Dow Jones)
30.03.23	Press Release: Addex Reports Full Year 2022 Financial Results and Provides Corporate Update (Dow Jones)
16.03.23	Press Release: Addex Announces Upcoming Conferences it will participate for H1 2023 (Dow Jones)
09.02.23	Press Release: Addex Regains Nasdaq Listing Compliance (Dow Jones)
06.02.23	Press Release: Addex Strategic Partner Completes Enrollment in ADX71149 Epilepsy Phase 2 Study Part 1 (Dow Jones)
19.01.23	Press Release: Addex Provides Corporate Update and Financial Guidance (Dow Jones)
08.12.22	Press Release: Addex and Indivior Extend Research Term of Substance Use Disorder GABAB Positive Allosteric Modulator Discovery Collaboration (Dow Jones)
11.11.22	Press Release: Addex Reports Q3 2022 Financial -2- (Dow Jones)
11.11.22	Press Release: Addex Reports Q3 2022 Financial Results and Provides Corporate Update (Dow Jones)
18.08.22	Press Release: Addex Reports 2022 Half Year and -2- (Dow Jones)
18.08.22	Press Release: Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update (Dow Jones)
15.08.22	Press Release: Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for Substance Use Disorders (Dow Jones)
26.07.22	Press Release: Addex Completes $4.2 Million Equity Financing (Dow Jones)
22.07.22	Aktien Schweiz von schwachen Daten belastet (Dow Jones)
22.07.22	Press Release: Addex Raises $4.2 million in Equity Financing (Dow Jones)
21.07.22	Aktien Schweiz schlagen sich mit freundlicher Tendenz wacker (Dow Jones)
21.07.22	Press Release: Addex Provides Corporate Update and Financial Guidance (Dow Jones)
17.06.22	Pre-market Movers: ADXN, FHTX, TBLT, TMDX, GP… (RTTNews)
17.06.22	Addex Terminates Phase 2b/3 Study Of Dipraglurant In Dyskinesia Associated With Parkinson's Disease (RTTNews)
17.06.22	Press Release: Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson's Disease due to Slow Recruitment Rate (Dow Jones)
27.05.22	Press Release: Addex Provides Update on Dipraglurant Blepharospasm Phase 2 Feasibility Clinical Study (Dow Jones)
19.05.22	Press Release: Addex Announces Participation in the H.C. Wainwright Global Investment Conference (Dow Jones)
13.05.22	Press Release: Addex Announces Participation in the 22nd BioEURquity Europe Conference (Dow Jones)
05.05.22	Press Release: Addex Reports Q1 2022 Financial Results (Dow Jones)
28.04.22	Press Release: Addex to Present at the Swiss Biotech Day 2022 (Dow Jones)
25.04.22	Press Release: Addex to Present at the B. Riley Securities Neuro & Ophthalmology Virtual Investor Conference (Dow Jones)
13.04.22	Press Release: Addex Therapeutics Completes Patient Enrollment for Dipraglurant Blepharospasm Phase 2 Clinical Study (Dow Jones)
24.03.22	Press Release: Addex to Present at the Bio-Europe Spring 2022 and Maxim Group -- 2022 Virtual Growth Conferences (Dow Jones)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Addex Therapeutics Ltd (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten